Literature DB >> 4403119

Use and abuse of hemopoietic cell grafts in immune deficiency diseases.

D W van Bekkum.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4403119     DOI: 10.1111/j.1600-065x.1972.tb01560.x

Source DB:  PubMed          Journal:  Transplant Rev        ISSN: 0082-5948


× No keyword cloud information.
  6 in total

1.  Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.

Authors:  A S Fauci; J E Balow; K R Pratt
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Reconstitution of defective cellular immunity with foetal thymus and dialysable transfer factor. Long-term studies in a patient with chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick; E A Ottenson; T K Smith; S A Wells; J F Burdick
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

3.  Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle.

Authors:  J M Vossen; J de Koning; D W van Bekkum; K A Dicke; V P Eysvoogel; W Hijmans; E van Loghem; J Rádl; J J van Rood; D van der Waay; L J Dooren
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

4.  Safety and efficacy of activated transfected killer cells for neutropenic fungal infections.

Authors:  Lin Lin; Ashraf S Ibrahim; Beverlie Baquir; Yue Fu; David Applebaum; Julie Schwartz; Amy Wang; Valentina Avanesian; Brad Spellberg
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

5.  Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977.

Authors:  A B Kenny; W H Hitzig
Journal:  Eur J Pediatr       Date:  1979-06-28       Impact factor: 3.183

Review 6.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.